$BENF

Beneficient (BENF): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Beneficient (BENF) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 AMENDED AND RESTATED STANDBY EQUITY PURCHASE AGREEMENT THIS AMENDED AND RESTATED STANDBY EQUITY PURCHASE AGREEMENT (this “ Agreement ”) dated as of June 26, 2026 and effective as of the Effective Date is made by and between YA II PN, LTD.

Original reporting
Published Jul 7, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 7, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$BENF
Neutral
medium confidence
Mentioned
$BENF
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BENFNeutralMed
01

Why it matters

The agreement updates the company’s equity financing framework: a $4M pre-paid advance split into two $2M tranches (with a 5% discount at purchase), plus the investor’s right to purchase up to $100M of Class A common stock over time subject to conditions and advance notice mechanics.

02

Market read

This is a primary disclosure of financing terms that can change dilution expectations and near-term capital availability for BENF.

03

What to watch

Key sensitivities are the 5% discount mechanics, the amortization/prepayment triggers, and how quickly the company can issue “Advance Shares” versus being constrained by outstanding promissory note balances and investor consent.

Relevance 6/10Novelty 6/10Timing: today’s SEC 8-K filing (after-hours) for financing terms and potential future dilution mechanics

Background

The 8-K Item 2.03 reports the creation of a direct financial obligation/off-balance sheet arrangement via an amended and restated standby equity purchase agreement.

Company-level read

Ticker impact

$BENFNeutralMedium confidence
Context

Beneficient files an 8-K disclosing an amended and restated standby equity purchase agreement with a $4M pre-paid advance and up to $100M share issuance right.

Expected impact

Near-term: modest negative-to-neutral bias as traders price dilution/financing overhang; longer-term impact depends on how quickly advances convert into equity and whether the company’s fundamentals offset dilution.

Evidence & confidence

The 8-K is a primary disclosure of financing terms (pre-paid advances, discount, triggers tied to 10-K filing and registration statement effectiveness). However, the excerpt does not provide draw timing beyond conditions, nor any stated use of proceeds or immediate share issuance amount beyond the $4M pre-paid advance.

Market effects

Adds another example of standby equity purchase/convertible pre-paid structures used by small/mid-cap issuers to manage capital needs and registration timing.

Primarily US-listed small-cap sentiment; limited direct regional spillover beyond Nasdaq microcap/SMID financing dynamics.

Low; the counterparty is a Cayman investor, but the disclosed impact is company-specific rather than a cross-border macro shock.

Counterpoint

Traders may treat the $4M pre-paid advance as immediate funding with defined conditions, potentially reducing near-term financing stress rather than increasing it.

Key entities

  • Beneficient

    Nasdaq-listed issuer (BENF) entering an amended and restated standby equity purchase agreement; provides terms for pre-paid advances and potential future share purchases.

  • YA II PN, LTD.

    Cayman Islands investor and counterparty to the standby equity purchase agreement.

Related articles

$BENFMedAI 8/10

Beneficient Reports First Quarter Fiscal 2027 Results

Beneficient (NASDAQ: BENF) reported fiscal 2027 first-quarter results ended June 30, 2026. The company entered its first collateral management services engagement with a Texas state-chartered bank and closed primary capital commitments totaling over $16 million. Investments with fair value rose to $212.5 million. Operating expenses fell 84.3% to $12.5 million, including a $1.8 million loss-contingency accrual.

$BENFMed

Beneficient (BENF): Results of Operations and Financial Condition

Beneficient (BENF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q127earningsrelease.htm EX-99.1 Document For Immediate Release BENEFICIENT REPORTS FIRST QUARTER FISCAL 2027 RESULTS Company Enters into First Collateral Management Services Engagement, Closes More than $16 Million in Primary Capital Commitments Dallas, TX. – August 14,

$BENFMed

Beneficient Closes $7.44 Million GP Primary Capital Transaction

Beneficient (NASDAQ: BENF) said it closed a $7.44 million GP primary capital transaction with Quartus AI Fund II LP, managed by Quartus Capital Partners. As consideration, the fund received about $7.44 million of Beneficient resettable convertible preferred stock convertible into Class A common. The deal may add about $7.44 million to ExAlt loan collateral and tangible book value.

$BENFMed

Beneficient Reports Fourth Quarter & Fiscal Year Ended March 31, 2026 Results

Beneficient (NASDAQ: BENF) reported fiscal 2026 results for the year ended March 31, 2026, including a fourth-quarter increase in operating expenses to $17.5M (vs. $14.3M) tied to $3.1M non-cash impairment and a $62.8M loss contingency for the year. The company said it resolved GWG Holdings litigation, regained Nasdaq compliance, generated $51.5M gross proceeds from asset sales, and paid off HH-BDH Credit Agreement principal. It also named James Silk CEO and announced a first collateral manageme

$BENFMed

Beneficient (BENF): Results of Operations and Financial Condition

Beneficient (BENF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q426earningsrelease.htm EX-99.1 Document For Immediate Release Exhibit 99.1 BENEFICIENT REPORTS FOURTH QUARTER & FISCAL YEAR ENDED MARCH 31, 2026 RESULTS Transformative Fiscal 2026 Focused on Addressing Legacy Issues While Strengthening Foundation of the Company Benefic